HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette Q3

This article was originally published in The Rose Sheet

Executive Summary

Blades and razors division net sales grew 7.8% to $1.1 bil. in the quarter, and profit from operations increased 5.1% to $434 mil., driven by the rollout of M3Power shaving system in the UK, Germany and Japan, as well as trade up in developing regions, Gillette reports during Oct. 28 analyst call. Firm's oral care division also benefited from new product launches, including Oral B Rembrandt whitening strips and pen, with sales up 27.4% to $418 mil.; however, profit from operations fell 3.1% to $62 mil. Personal care segment sales grew 7.2% to $253 mil., and profit from operations jumped 30.8% to $34 mil. Gillette spent heavily on advertising, up 45% in the quarter to 11.8% of sales, reflecting investment behind new product programs and effort to promote higher consumption and trade up in developing markets, firm notes. Net sales increased 11.9% to $2.7 bil., and net income grew 14.2% to $475 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel